As needed inhaled corticosteroid and long-acting beta-agonist for Medication Nonadherence
This trial seeks to assess why people don't take their inhalers & test a new approach to reduce asthma hospitalization due to non-adherence.
- Childhood Asthma
- Medication Nonadherence
1 Primary · 11 Secondary · Reporting Duration: 24 weeks
2 Treatment Groups
As needed inhaled corticosteroid and long-acting beta-agonist
1 of 2
Standard therapy: maintenance inhaled corticosteroid and as needed short-acting ...
1 of 2
40 Total Participants · 2 Treatment Groups
Primary Treatment: As needed inhaled corticosteroid and long-acting beta-agonist · Has Placebo Group · Phase 1 & 2
Who is running the clinical trial?
Age 12 - 17 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is the upper age limit for this experiment beyond eighty-five years old?
"The target demographic for this research is children aged 12-17." - Anonymous Online Contributor
What type of participants would be best suited to enroll in this medical study?
"The eligibility criteria for this clinical trial is composed of participants aged 12 to 17 with a history of medication nonadherence. The research team hopes to recruit approximately 40 individuals that meet these requirements." - Anonymous Online Contributor
What is the projected enrollment size of this research initiative?
"Affirmative. According to clinicaltrials.gov, this medical trial was posted on April 1st 2022 and is open for enrollment as of January 9th 2023. The study aims to recruit 40 patients from one specific site location." - Anonymous Online Contributor
Is there any availability for applicants to join this clinical trial?
"Clinicaltrials.gov reveals that this study is actively seeking participants; it was first uploaded to the website on April 1st 2022, and its details were most recently modified on January 9th 2023." - Anonymous Online Contributor